APA (7th ed.) Citation

Goueffic, Y., Sauguet, A., Desgranges, P., Feugier, P., Rosset, E., Ducasse, E., . . . Maurel, B. (2019). TCT-62 A Polymer-Free Paclitaxel-Eluting Stent (Zilver PTX) Versus a Bare-Metal Stent (Misago) for De Novo Femoropopliteal Lesions (BATTLE): A Randomized Trial. Journal of the American College of Cardiology (JACC), 74(13), B62. https://doi.org/10.1016/j.jacc.2019.08.097

Chicago Style (17th ed.) Citation

Goueffic, Yann, et al. "TCT-62 A Polymer-Free Paclitaxel-Eluting Stent (Zilver PTX) Versus a Bare-Metal Stent (Misago) for De Novo Femoropopliteal Lesions (BATTLE): A Randomized Trial." Journal of the American College of Cardiology (JACC) 74, no. 13 (2019): B62. https://doi.org/10.1016/j.jacc.2019.08.097.

MLA (9th ed.) Citation

Goueffic, Yann, et al. "TCT-62 A Polymer-Free Paclitaxel-Eluting Stent (Zilver PTX) Versus a Bare-Metal Stent (Misago) for De Novo Femoropopliteal Lesions (BATTLE): A Randomized Trial." Journal of the American College of Cardiology (JACC), vol. 74, no. 13, 2019, p. B62, https://doi.org/10.1016/j.jacc.2019.08.097.